These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26026944)

  • 1. Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
    Murchison A; Kitley J; Leite MI; Küker W; Palace J
    J Neurol Sci; 2015 Aug; 355(1-2):49-53. PubMed ID: 26026944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
    Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
    JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of conventional MRI parameters in first spinal attacks of neuromyelitis optica spectrum disorder.
    Bonnan M; Debeugny S; Mejdoubi M; Cabre P
    Mult Scler; 2020 Apr; 26(4):468-475. PubMed ID: 30843448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
    Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
    J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies.
    Chang KH; Lyu RK; Chen CM; Wu YR; Chang HS; Huang CC; Kuo HC; Chu CC; Hsu WC; Ro LS
    Mult Scler; 2013 Mar; 19(3):299-307. PubMed ID: 22829325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
    Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS
    BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
    Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
    Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
    Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
    Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection.
    Heerlein K; Jarius S; Jacobi C; Rohde S; Storch-Hagenlocher B; Wildemann B
    J Neurol Sci; 2009 Jan; 276(1-2):184-6. PubMed ID: 18805556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
    Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP
    Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-aquaporin-4 antibody positivity in neuromyelitis optica is associated with lesion activity.
    Liu Y; Han Y; Duan Y; Huang J; Ren Z; Butzkueven H; Li K
    Eur Neurol; 2013; 70(1-2):113-6. PubMed ID: 23860467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
    Park JS; Hwang SJ; Shin JH; Kim DS
    J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
    Xie L; Long Y; Yang N; Shan F; Fan Y; Zhong R; Wu L; Yin J; Gao Q; Cong G
    Neuroimmunomodulation; 2015; 22(5):337-41. PubMed ID: 25721331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
    Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU
    Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.
    Jarius S; Ruprecht K; Wildemann B; Kuempfel T; Ringelstein M; Geis C; Kleiter I; Kleinschnitz C; Berthele A; Brettschneider J; Hellwig K; Hemmer B; Linker RA; Lauda F; Mayer CA; Tumani H; Melms A; Trebst C; Stangel M; Marziniak M; Hoffmann F; Schippling S; Faiss JH; Neuhaus O; Ettrich B; Zentner C; Guthke K; Hofstadt-van Oy U; Reuss R; Pellkofer H; Ziemann U; Kern P; Wandinger KP; Bergh FT; Boettcher T; Langel S; Liebetrau M; Rommer PS; Niehaus S; Münch C; Winkelmann A; Zettl U UK; Metz I; Veauthier C; Sieb JP; Wilke C; Hartung HP; Aktas O; Paul F
    J Neuroinflammation; 2012 Jan; 9():14. PubMed ID: 22260418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.